Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Oct 2013 | $48 M | No. 3 | $10 to $50 million | equity, options | SEC | |
| Jul 2010 | $34 M | No. 2 | $10 to $50 million | equity | SEC | |
| Jun 2008 | $14 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Immune Design Corp. chose not to state its revenue in its newest notice of a funding round (Oct 2013).
SEC Form D · Oct 2013
The industry group it chose in its notices: Biotechnology.
SEC Form D · Oct 2013
That is all the official record says: Immune Design Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
8 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Alta Partners Management VIII, LLC | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Alta Partners VIII, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Column Group GP, LP | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Column Group L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| ProQuest Associates IV LLC | Other | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| ProQuest Investments IV, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Versant Side Fund III, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Versant Venture Capital III, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 8 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Carlos V Paya | Executive officer | Oct 2013 |
| James T Rickey | Executive officer | Oct 2013 |
| Jan Henrik T ter Meulen | Executive officer | Oct 2013 |
| Richard T Kenney | Executive officer | Oct 2013 |
| Stephen R Brady | Executive officer | Oct 2013 |
| Wayne R Gombotz | Executive officer | Oct 2013 |
| Carlos V. Paya | Executive officer | Jan 2013 |
| David Paul Parker | Executive officer | Jan 2013 |
| James Paul Rickey | Executive officer | Jan 2013 |
| Wayne Paul Gombotz | Executive officer | Jan 2013 |
| Steve Reed | Executive officer | Oct 2011 |
| Bruce Carter | Executive officer | Aug 2010 |
| Sammy Farah | Executive officer | Aug 2010 |
| Thomas Dubensky | Executive officer | Aug 2010 |
| Steven Reed | Executive officer | Jul 2009 |
| Alain V Schreiber | Director | Oct 2013 |
| Brian V Atwood | Director | Oct 2013 |
| Bruce V Carter | Director | Oct 2013 |
| Carlos V Paya | Director | Oct 2013 |
| David V Baltimore | Director | Oct 2013 |
| Ed V Penhoet | Director | Oct 2013 |
| Peter V Svennilson | Director | Oct 2013 |
| Alain V. Schreiber | Director | Jan 2013 |
| Brian V. Atwood | Director | Jan 2013 |
| Bruce LA Carter | Director | Jan 2013 |
| Carlos V. Paya | Director | Jan 2013 |
| David V. Baltimore | Director | Jan 2013 |
| Edward V. Penhoet | Director | Jan 2013 |
| Roger V. Perlmutter | Director | Jan 2013 |
| Alain Schreiber | Director | Oct 2011 |
| Brian Atwood | Director | Oct 2011 |
| Bruce Carter | Director | Oct 2011 |
| David Baltimore | Director | Oct 2011 |
| Edward Penhoet | Director | Oct 2011 |
| Richard Klausner | Director | Oct 2011 |
| Steve Reed | Director | Oct 2011 |
| Ed Penhoet | Director | Jul 2009 |
| Steven Reed | Director | Jul 2009 |